{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo-+Phosphate+buffered+saline+%28PBS%29", "query": { "intervention": "Placebo- Phosphate buffered saline (PBS)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 51, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo-+Phosphate+buffered+saline+%28PBS%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-01T16:23:13.185Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00768066", "title": "The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Stem Cell Transplantation", "Ventricular Dysfunction, Left" ], "interventions": [ { "name": "Autologous human mesenchymal cells (hMSCs)", "type": "BIOLOGICAL" }, { "name": "Autologous human bone marrow cells (hBMCs)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "21 Years to 90 Years" }, "enrollment_count": 65, "start_date": "2008-08", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2015-12-14", "last_synced_at": "2026-10-01T16:23:13.185Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00768066" }, { "nct_id": "NCT03911076", "title": "Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "ASC-US", "ASC-H", "LSIL" ], "interventions": [ { "name": "PVX-2", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "PapiVax Biotech, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "25 Years to 70 Years · Female only" }, "enrollment_count": 16, "start_date": "2019-05-22", "completion_date": "2022-06-08", "has_results": false, "last_update_posted_date": "2024-06-17", "last_synced_at": "2026-10-01T16:23:13.185Z", "location_count": 6, "location_summary": "Port Saint Lucie, Florida • Newark, New Jersey • Fairfield, Ohio + 3 more", "locations": [ { "city": "Port Saint Lucie", "state": "Florida" }, { "city": "Newark", "state": "New Jersey" }, { "city": "Fairfield", "state": "Ohio" }, { "city": "Austin", "state": "Texas" }, { "city": "Corpus Christi", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03911076" }, { "nct_id": "NCT00587990", "title": "Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Stem Cell Transplantation", "Ventricular Dysfunction, Left" ], "interventions": [ { "name": "Lower dose mesenchymal stem cell (MSC) injection", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "GENETIC" }, { "name": "Higher dose MSC injection", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "GENETIC" ], "sponsor": "Joshua M Hare", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "21 Years to 80 Years" }, "enrollment_count": 9, "start_date": "2007-11", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2019-09-10", "last_synced_at": "2026-10-01T16:23:13.185Z", "location_count": 2, "location_summary": "Miami, Florida • Baltimore, Maryland", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00587990" }, { "nct_id": "NCT05604521", "title": "A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Malaria", "Malaria,Falciparum" ], "interventions": [ { "name": "PfSPZ Vaccine", "type": "BIOLOGICAL" }, { "name": "PfSPZ Challenge (7G8)", "type": "BIOLOGICAL" }, { "name": "Normal Saline", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Sanaria Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 31, "start_date": "2022-12-06", "completion_date": "2023-09-05", "has_results": true, "last_update_posted_date": "2024-11-25", "last_synced_at": "2026-10-01T16:23:13.185Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05604521" }, { "nct_id": "NCT03275389", "title": "A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "D-SUIV cH8/1N1+AS03", "type": "BIOLOGICAL" }, { "name": "D-SUIV cH5/1N1+AS03", "type": "BIOLOGICAL" }, { "name": "D-SUIV cH11/1N1+AS03", "type": "BIOLOGICAL" }, { "name": "D-SUIV cH8/1N1+AS01", "type": "BIOLOGICAL" }, { "name": "D-SUIV cH5/1N1+AS01", "type": "BIOLOGICAL" }, { "name": "D-SUIV cH11/1N1+AS01", "type": "BIOLOGICAL" }, { "name": "D-SUIV cH8/1N1", "type": "BIOLOGICAL" }, { "name": "D-SUIV cH5/1N1", "type": "BIOLOGICAL" }, { "name": "D-SUIV cH11/1N1", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Fluarix Quadrivalent", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "39 Years", "sex": "ALL", "summary": "18 Years to 39 Years" }, "enrollment_count": 470, "start_date": "2017-09-08", "completion_date": "2020-03-26", "has_results": true, "last_update_posted_date": "2021-05-07", "last_synced_at": "2026-10-01T16:23:13.185Z", "location_count": 5, "location_summary": "South Miami, Florida • Wichita, Kansas • Rochester, New York + 2 more", "locations": [ { "city": "South Miami", "state": "Florida" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Rochester", "state": "New York" }, { "city": "Austin", "state": "Texas" }, { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03275389" }, { "nct_id": "NCT00285259", "title": "Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Lymphoblastic Leukemia", "Chronic Myelogenous Leukemia", "Acute Myelogenous Leukemia", "Hodgkin's Lymphoma", "Non-Hodgkin's Lymphoma", "Myelodysplastic Syndrome" ], "interventions": [ { "name": "VCL-CB01", "type": "BIOLOGICAL" }, { "name": "Phosphate-buffered Saline (PBS)", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Astellas Pharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 112, "start_date": "2006-01-31", "completion_date": "2010-11-30", "has_results": false, "last_update_posted_date": "2024-10-21", "last_synced_at": "2026-10-01T16:23:13.185Z", "location_count": 22, "location_summary": "Tucson, Arizona • Duarte, California • Denver, Colorado + 17 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00285259" }, { "nct_id": "NCT01169077", "title": "EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum Malaria", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Plasmodium Falciparum Malaria" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "EP-1300", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 39, "start_date": "2010-08", "completion_date": "2012-07", "has_results": false, "last_update_posted_date": "2012-11-16", "last_synced_at": "2026-10-01T16:23:13.185Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01169077" }, { "nct_id": "NCT03769194", "title": "Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lyme Borreliosis" ], "interventions": [ { "name": "VLA15", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 572, "start_date": "2018-12-17", "completion_date": "2020-10-02", "has_results": true, "last_update_posted_date": "2023-01-10", "last_synced_at": "2026-10-01T16:23:13.185Z", "location_count": 6, "location_summary": "Milford, Connecticut • Stamford, Connecticut • Binghamton, New York + 3 more", "locations": [ { "city": "Milford", "state": "Connecticut" }, { "city": "Stamford", "state": "Connecticut" }, { "city": "Binghamton", "state": "New York" }, { "city": "Endwell", "state": "New York" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03769194" }, { "nct_id": "NCT04546724", "title": "Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chikungunya Virus Infection" ], "interventions": [ { "name": "VLA1553", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Valneva Austria GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4128, "start_date": "2020-09-17", "completion_date": "2021-10-15", "has_results": true, "last_update_posted_date": "2023-06-28", "last_synced_at": "2026-10-01T16:23:13.185Z", "location_count": 44, "location_summary": "Chandler, Arizona • Phoenix, Arizona • Tempe, Arizona + 39 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04546724" }, { "nct_id": "NCT00262080", "title": "Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hereditary Angioedema (HAE)" ], "interventions": [ { "name": "ecallantide", "type": "DRUG" }, { "name": "Phosphate Buffer Saline (PBS),", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": null, "sex": "ALL", "summary": "10 Years and older" }, "enrollment_count": 91, "start_date": "2005-12-31", "completion_date": "2007-02-28", "has_results": true, "last_update_posted_date": "2021-06-11", "last_synced_at": "2026-10-01T16:23:13.185Z", "location_count": 1, "location_summary": "Wheaton, Maryland", "locations": [ { "city": "Wheaton", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00262080" } ] }